You have 9 free searches left this month | for more free features.

glioblastoma

Showing 26 - 50 of 2,245

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma (GBM) Trial in Basel (Advanced diffusion-weighted MRI (ADW-MRI))

Recruiting
  • Glioblastoma (GBM)
  • Advanced diffusion-weighted MRI (ADW-MRI)
  • Basel, Switzerland
    University Hospital Basel
Jun 21, 2023

Experiences of Glioblastoma Patients

Not yet recruiting
  • Glioblastoma
    • (no location specified)
    Feb 4, 2023

    Glioblastoma Trial in Aarhus (Escalated proton therapy)

    Not yet recruiting
    • Glioblastoma
    • Escalated proton therapy
    • Aarhus, Denmark
      Danish Center for Particle Therapy
    Mar 2, 2023

    Recurrent Glioblastoma, Glioblastoma Multiforme, GBM Trial in Charlottesville (5-ALA and Low-Intensity Focused Ultrasound (SDT))

    Not yet recruiting
    • Recurrent Glioblastoma
    • +2 more
    • 5-ALA and Low-Intensity Focused Ultrasound (SDT)
    • Charlottesville, Virginia
      University of Virginia
    Sep 10, 2023

    MGMT-Unmethylated Glioblastoma Trial (Etoposide Plus Cisplatin)

    Not yet recruiting
    • MGMT-Unmethylated Glioblastoma
    • Etoposide Plus Cisplatin
    • (no location specified)
    Jan 12, 2023

    Glioblastoma Trial (Tislelizumab and Bevacizumab)

    Not yet recruiting
    • Glioblastoma
    • Tislelizumab and Bevacizumab
    • (no location specified)
    Apr 12, 2023

    GBM Trial (Lenvatinib, Pembrolizumab, Tumor Treating Fields (TTFields))

    Not yet recruiting
    • GBM
    • (no location specified)
    Aug 2, 2023

    Glioblastoma, Glioblastoma, IDH-wildtype Trial in Rome (Biomolecular tumor analysis)

    Recruiting
    • Glioblastoma
    • Glioblastoma, IDH-wildtype
    • Biomolecular tumor analysis
    • Rome, Italy
      Fondazione Policlinico Universitario A. Gemelli IRCCS
    Mar 6, 2023

    Glioblastoma Trial (Bevacizumab, PD-L1 t-haNK, N-803)

    Not yet recruiting
    • Glioblastoma
    • (no location specified)
    Sep 25, 2023

    Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Giant Cell Glioblastoma
    • +2 more
    • Laboratory Biomarker Analysis
    • Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
    • Rochester, Minnesota
      Mayo Clinic
    Jan 4, 2023

    Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme Trial in New York (Tissue autograft of pedicled temporoparietal fascial

    Recruiting
    • Glioma, Malignant
    • +6 more
    • Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
    • New York, New York
      Lenox Hill Brain Tumor Center
    Jul 13, 2023

    [18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)

    Recruiting
    • Glioblastoma Multiforme of Brain
    • Positron Emission Tomography-Computerised Tomography (PET-CT)
    • London, United Kingdom
      Imperial College Healthcare NHS Trust
    Mar 23, 2023

    Recurrent Glioblastoma Trial in Brussels (Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV,

    Not yet recruiting
    • Recurrent Glioblastoma
    • Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV
    • +2 more
    • Brussels, Belgium
      UZ Brussel
    Oct 23, 2023

    Glioblastoma Trial in Louisville (Pembrolizumab and Temozolomide)

    Recruiting
    • Glioblastoma
    • Pembrolizumab and Temozolomide
    • Louisville, Kentucky
      James Graham Brown Cancer Ctr.
    Jan 18, 2023

    Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))

    Active, not recruiting
    • Glioblastoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Jan 30, 2023

    Glioblastoma Trial (RZ-001, VGCV)

    Not yet recruiting
    • Glioblastoma
    • (no location specified)
    Oct 22, 2023

    Glioblastoma Trial (TTFields)

    Not yet recruiting
    • Glioblastoma
    • TTFields
    • (no location specified)
    Nov 15, 2023

    Glioblastoma Trial (Dose escalation of radiation dose beyond the therapeutic standard)

    Not yet recruiting
    • Glioblastoma
    • Dose escalation of radiation dose beyond the therapeutic standard
    • (no location specified)
    May 13, 2023

    Advanced Glioblastoma, Metastatic Melanoma in the CNS, MGMT-Unmethylated Glioblastoma Trial in Ramat Gan (Crizanlizumab-Tmca 10

    Not yet recruiting
    • Advanced Glioblastoma
    • +2 more
    • Crizanlizumab-Tmca 10 MG/1 ML Intravenous Solution [ADAKVEO]
    • Nivolumab 10 MG/1 ML Intravenous Solution [OPDIVO]
    • Ramat Gan, Israel
      Sheba medical center
    Jun 11, 2023

    Recurrent Glioblastoma Multiforme Trial in Beijing (SNC-109 CAR-T Cells)

    Recruiting
    • Recurrent Glioblastoma Multiforme
    • SNC-109 CAR-T Cells
    • Beijing, China
      Chinese PLA General Hospital
    May 11, 2023

    Glioblastoma, Glioma, Malignant Trial in Rome (Biological sample collection, Dissecting ciliogenesis players, Validating

    Recruiting
    • Glioblastoma
    • Glioma, Malignant
    • Biological sample collection
    • +2 more
    • Rome, Italy
      Fondazione Policlinico Universitario A. Gemelli IRCCS
    Mar 6, 2023

    Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

    Recruiting
    • Astrocytoma, Grades II, III and IV
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    Glioblastoma Trial in Valladolid (GTR surgery, AI-guided surgery)

    Recruiting
    • Glioblastoma
    • GTR surgery
    • AI-guided surgery
    • Valladolid, Spain
      University Hospital Rio Hortega
    Feb 21, 2023

    Glioblastoma, IDH-wildtype Trial in Beijing (Elemene, Placebo)

    Not yet recruiting
    • Glioblastoma, IDH-wildtype
    • Beijing, China
      Peking Union Medical College Hospital
    Apr 22, 2023

    Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)

    Active, not recruiting
    • Astrocytoma, Grade IV
    • +3 more
    • Radiation
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023